Stockscreener 앱 받기
1.50
0.66%
-0.01
전일 마감가:
$1.51
열려 있는:
$1.51
하루 거래량:
129.10K
Relative Volume:
2.61
시가총액:
$8.74M
수익:
-
순이익/손실:
$-14.29M
주가수익비율:
-0.3759
EPS:
-3.99
순현금흐름:
$-12.27M
1주 성능:
+4.75%
1개월 성능:
-0.66%
6개월 성능:
-5.06%
1년 성능:
-50.82%
1일 변동 폭
$1.48
$1.57
1주일 범위
$1.395
$1.57
52주 변동 폭
$1.37
$5.01
Aprea Therapeutics Inc Stock (APRE) Company Profile
명칭
Aprea Therapeutics Inc
전화
215-948-4119
주소
3805 OLD EASTON ROAD, DOYLESTOWN, MA
APRE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APRE
Aprea Therapeutics Inc
|
1.50 | 8.80M | 0 | -14.29M | -12.27M | -3.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.18 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
475.24 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.07 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
818.45 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
317.44 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Aprea Therapeutics Inc Stock (APRE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-12-28 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-12-16 | 개시 | Berenberg | Buy |
| 2020-09-29 | 재개 | JP Morgan | Neutral |
| 2020-06-22 | 개시 | H.C. Wainwright | Neutral |
| 2020-04-21 | 개시 | Robert W. Baird | Outperform |
| 2019-10-28 | 개시 | JP Morgan | Neutral |
| 2019-10-28 | 개시 | Morgan Stanley | Equal-Weight |
| 2019-10-28 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Aprea Therapeutics Inc 주식(APRE)의 최신 뉴스
Visualizing Aprea Therapeutics Inc. stock with heatmaps2025 Risk Factors & Consistent Profit Trading Strategies - newser.com
Risk vs reward if holding onto Aprea Therapeutics Inc.Earnings Recap Summary & Community Supported Trade Ideas - newser.com
Is Aprea Therapeutics Inc. stock poised for growthEarnings Beat & Growth Focused Stock Reports - newser.com
Aprea sets 1,100 mg dose for ATR inhibitor, shifts focus to combinations - Investing.com Canada
Aprea sets 1,100 mg dose for ATR inhibitor, shifts focus to combinations By Investing.com - Investing.com South Africa
Aprea Therapeutics Shifts Focus to Combination Therapies - TipRanks
Aprea Therapeutics Establishes Recommended Phase 2 Dose for ATRN-119 - TradingView
Aprea Therapeutics Establishes Recommended Phase 2 Dose (RP2D) for ATRN-119, Considering Combination Therapies - The Manila Times
1,100 mg RP2D: Aprea Therapeutics shifts ATRN-119 to combination focus, pauses monotherapy enrollment - Stock Titan
Aprea Therapeutics Announces Presentations at - GlobeNewswire
Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics - Stock Titan
Sentiment analysis tools applied to Aprea Therapeutics Inc.Market Activity Summary & Fast Exit/Entry Strategy Plans - newser.com
Developing predictive dashboards with Aprea Therapeutics Inc. dataInsider Selling & AI Powered Market Trend Analysis - newser.com
How to recover losses in Aprea Therapeutics Inc. stock2025 Technical Overview & Technical Buy Zone Confirmation - newser.com
Using economic indicators to assess Aprea Therapeutics Inc. potential2025 Breakouts & Breakdowns & Safe Entry Zone Tips - newser.com
Should you wait for a breakout in Aprea Therapeutics Inc.July 2025 Selloffs & Smart Investment Allocation Insights - newser.com
Aprea Therapeutics (NASDAQ:APRE) Trading Down 3% – Here’s What Happened - Defense World
Historical volatility pattern of Aprea Therapeutics Inc. visualizedPortfolio Growth Summary & Daily Growth Stock Tips - newser.com
Can Aprea Therapeutics Inc. rally from current levelsWeekly Trend Report & Long-Term Growth Stock Strategies - newser.com
How sentiment analysis helps forecast Aprea Therapeutics Inc.Market Rally & Free Safe Capital Growth Stock Tips - newser.com
Published on: 2025-10-03 04:24:53 - newser.com
How to integrate Aprea Therapeutics Inc. into portfolio analysis toolsJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com
Reversal indicators forming on Aprea Therapeutics Inc. stockJobs Report & Verified Chart Pattern Signals - newser.com
What analysts say about Aprea Therapeutics Inc stockPrice Support Zones & Low Cost Trading Plans - earlytimes.in
Published on: 2025-09-30 01:07:35 - newser.com
Published on: 2025-09-29 04:10:00 - newser.com
What drives Aprea Therapeutics Inc stock priceTrade Execution Strategies & Big Returns Small Capital - earlytimes.in
Is Aprea Therapeutics Inc a good long term investmentMACD Trading Signals & Rapid Capital Trading Tips - Early Times
Published on: 2025-09-27 17:04:35 - newser.com
Live market analysis of Aprea Therapeutics Inc.2025 Sector Review & Stock Portfolio Risk Control - newser.com
Using portfolio simulators with Aprea Therapeutics Inc. includedJuly 2025 Trends & Weekly Market Pulse Alerts - newser.com
Aprea Therapeutics Inc (APRE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.83%
0.88%
자본화:
|
볼륨(24시간):